| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Y-39983 | GDSC1000 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | AA-COCF3 | CTRPv2 | pan-cancer | AAC | 0.0028 | 0.9 |
| mRNA | B02 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | CIL55 | CTRPv2 | pan-cancer | AAC | 0.0045 | 0.9 |
| mRNA | BRD-K33514849 | CTRPv2 | pan-cancer | AAC | -0.0089 | 0.9 |
| mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | CAL-101 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | Sildenafil | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | -0.0025 | 0.9 |